Safety of kudzu root in people with type 2 diabetes
Part of Hormones & metabolism clinical trials.
This study reviews the safety of kudzu root (a traditional herbal remedy) in people with type 2 diabetes who have taken it in specific ways (like in high doses or for a long time) and then had a side effect. By looking back at your experience, researchers hope to understand better who might be at risk and how to use it more safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with type 2 diabetes.
- You have taken kudzu root (Pueraria lobata) in some form, like dried slices or cubes.
- You fit at least one special situation, such as high-dose use, long-term use (3+ months, 3+ times a week), age 80 or older, pregnancy, breastfeeding, having allergies, liver problems, or kidney problems.
- You had a side effect or unusual symptom within one month after taking kudzu root.
- You do not have type 1 diabetes or gestational diabetes, and you did not use kudzu root in compound forms like injections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study will test how eating durian for 2 weeks affects blood sugar control in people with type 2 diabetes. If you qualify, you'll eat durian as part of the study and wear a continuous glucose monitor to track your blood sugar.
This study tests a new Chinese herbal formula to see if it can help control blood sugar in people with type 2 diabetes. It might offer a natural treatment option for those who have not used diabetes medications recently.
This study tests a new medicine called LC-Z300-01 to see if it is safe and works well for people with type 2 diabetes. It may help lower blood sugar levels.
This study tests a traditional Chinese medicine treatment to help people with type 2 diabetes achieve remission. It looks at how well it works and why it may work differently for different people.
This trial tests an experimental drug called SHR-3167 in people with type 2 diabetes. The goal is to see how the drug works in the body and how it affects blood sugar. It may be an option for adults who have had diabetes for at least 6 months.
This trial tests a drug called urinary kallidinogenase in people who have had a stroke and also have type 2 diabetes. The drug may help improve recovery after a stroke.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.